908 Devices (908 Devices) EBIT per Share : $-1.14 (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is 908 Devices EBIT per Share?

908 Devices's EBIT per Share for the three months ended in Mar. 2024 was $-0.34. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-1.14.

During the past 3 years, the average EBIT per Share Growth Rate was -7.70% per year. During the past 5 years, the average EBIT per Share Growth Rate was -26.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for 908 Devices's EBIT per Share or its related term are showing as below:

MASS' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -32.5 Med: -22.1 Max: -7.7
Current: -7.7

During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of 908 Devices was -7.70% per year. The lowest was -32.50% per year. And the median was -22.10% per year.

MASS's 3-Year EBIT Growth Rate is ranked worse than
66.44% of 727 companies
in the Medical Devices & Instruments industry
Industry Median: 5.8 vs MASS: -7.70

908 Devices's EBIT for the three months ended in Mar. 2024 was $-10.99 Mil.

908 Devices EBIT per Share Historical Data

The historical data trend for 908 Devices's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

908 Devices EBIT per Share Chart

908 Devices Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-0.60

-2.16

-0.78

-1.06

-1.13

908 Devices Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															-0.38	-0.29	-0.28	-0.23	-0.34

908 Devices EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

908 Devices's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-36.409	/	32.239
=	-1.13

908 Devices's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-10.987	/	32.711
=	-0.34

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.14

908 Devices (NAS:MASS) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

908 Devices EBIT per Share Related Terms

Thank you for viewing the detailed overview of 908 Devices's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

908 Devices (908 Devices) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » 908 Devices Inc (NAS:MASS) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

645 Summer Street, Boston, MA, USA, 02210

Website

https://www.908devices.com

908 Devices Inc manufactures medical devices. It has developed an innovative suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets.

Executives

Griffith Joseph H. Iv	officer: Chief Financial Officer	68 ELM STREET, HOPKINTON MA 01748
Christopher D. Brown	officer: Chief Technology Officer	C/O 908 DEVICES INC., 645 SUMMER STREET, BOSTON MA 02210
Kevin J. Knopp	director, officer: President and CEO	C/O 908 DEVICES INC., 645 SUMMER STREET, BOSTON MA 02210
Michael S. Turner	officer: VP, General Counsel	C/O 908 DEVICES INC., 645 SUMMER STREET, BOSTON MA 02210
Maura Fitzpatrick	officer: VP, Product Management & Mktg	908 DEVICES INC., 645 SUMMER STREET, BOSTON MA 02210
Mark Spoto	director	C/O 908 DEVICES INC., 645 SUMMER STREET, BOSTON MA 02210
Michele Fournier	officer: Chief People Officer	908 DEVICES INC., 645 SUMMER STREET, BOSTON MA 02210
Trent A. Basarsky	officer: Vice President, Commercial	C/O PROTEINSIMPLE, 3040 OAKMEAD VILLAGE DRIVE, SANTA CLARA CA 95051
John Kenneweg	officer: Vice President, Government	C/O 908 DEVICES INC., 645 SUMMER STREET, BOSTON MA 02210
Anthony Hunt	director	41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM MA 02452
Nicolas Barthelemy	director	1750 BELLA LAGUNA CT, ENCINITAS CA 92024
Marcia Eisenberg	director	C/O 908 DEVICES INC., 645 SUMMER STREET, BOSTON MA 02210
Jeffrey P. George	director	C/O AMNEAL PHARMACEUTICALS, INC., 400 CROSSING BOULEVARD, BRIDGEWATER NJ 08807
Fenel M Eloi	director	C/O INTERLEUKIN GENETICS INC, 135 BEAVER STREET, WALTHAM MA 02452
Keith Crandell	director, 10 percent owner	8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO IL 60631